Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Once upon a time I was in here at 6p for the rise (pardon the pun) on Sildenafil (Viagra) hopes
Did ok as I sold into the rise up to 32p.
I've been back a couple of times for a trade, and lost a few quid. There's always been some renewed promise, but it never seems to materialise.
However, with this latest RNS , it does feel like it's now or never for the company to achieve some collaboration or joint venture tie-up.
As stated in the RNS this is going to take a large amount of capital from now on to get it going.
They need a collaboration else this will be diluted to death.
I thought it was a pretty good RNS and bought back in on promise collaboration with major US R&D company.
Will it all be BS again ? We'll see. Hope not.
Think it will rise significantly, once investment is forthcoming.
Good to see there are loads of shares being bought and sold today.
it means at least we are on peoples radar.
Seems like they dont want this to rise,... just yet !!!
Exactly this Homer, Marketing is the key to prospective investment.
as someone who is constantly searching the company name i would expect my social media feeds to be filled with advertisements from algorithm pick ups. i have never seen anything unless it's from a link i have clicked on this forum.
They wouldn't even need to employ someone full time. it's simple and easy to carry out as a part of an administrators role.
N4P need a new broker and they need to employ a young media person.
I work with a company who have a huge social media presence and it costs peanuts. They have a couple of brilliant young people who work wonders on a tiny budget. N4P is utterly useless in promoting itself and spreading the word.
Have to say all those trades at the bell and the price doesn't move.
AIM is ridiculous.
Fantastic news
Could NT not even see how the RNS reads with U and S on different lines and many words on different lines which makes it look incompetent. If he had missed out " the " perhaps it would read better. Us shareholders have funded his long awaited collaboration and this will not generate cash. Pharma deal is not near term. Dissappointed with his wording and deal making. Years of near term no longer mean even one deal.
Down to our last million. ‘Sufficient to finish current work.’ Presumably doesnt include getting Nanogenics in to clinical trials next year. When you consider the cost of a year in the aim market that is pretty tight, but expected. Wonder how they earned £1900? So possible farm out against another raise. It does look like opportunities opening in multiple areas. Gl all
This is exactly the reassurance investors needed.
Well done to the company, this is much better news.
N4P in "advanced stages of finalising a collaboration with an independent global R&D leader based in the US" - RNS today
CEO: "We are closer than ever before to agreeing a collaboration which would see Nuvec® being applied to other technologies with a view to co-marketing the resultant technology to big pharma and I look forward to making further announcements on this in the near future"
Sounds like a transformational announcement in "the near future" is on the way....
Good luck, Brighty
Nigels comment.
"Our IP position has strengthened and we believe we are closer than ever before to agreeing a collaboration which would
see Nuvec® being applied to other technologies with a view to co-marketing the resultant technology to big pharma and I
look forward to making further announcements on this in the near future"
Sounds quite upbeat to me....let's see how things pan out in the coming months gla
Collaborations
· Company continues to seek partners to develop its Nuvec® technology and is in the
advanced stages of finalising a collaboration with an independent global R&D leader based
in the US with the aim of securing a co-marketing agreement following initial studies.
That sounds promising.
I have also seen the glory days of N30p however i simply watched as that slowly disappeared before my eyes.
Yes a few little wins and encouraging news of late. We have seen n4p, n3p, n2p,. n1p and now even n0.6p so hopefully the train will at some point move in the opposite direction.
GLA.
My words are often the kiss of death however we seem to be holding well at .9 of a penny.
25% over the month. i like many of you still have a long way to go before i see any profits but i'm happy to celebrate little wins. i'm hoping the next RNS doesn't bring a downfall as we have seen so many times before.
fingers firmly crossed. 7 years invested here, what's another year or two?
All these 'positive findings' but as of yet zero commercial traction. It's time to deliver for N4P.
All good points.
In the last online presentation by the CEO, he said that any funding would be arranged with any potential partners.
There are many different drug delivery companies trialing in many areas of medicine. I’m not sure it is a one size fits all or winner takes all race. N4p have two very specific vehicles Nanogenics and Nuvec fully patented. Whilst they have partnerships and trials with different universities, they have not got the clout of bill Gates foundation or a European foundation like some competitors in Nanotechnology. Their clinical trials seem further away than some and as yet no licensing agreements , they are conducting their research and trials in different areas to their competitors , specifically with Nanogenics. Oral vaccination seems a much more competitive area, but they could still succeed in that too in some form. Much to play for
The pharma that moves first will get the rewards.
Nuvec looks like the real deal.
Https://invst.ly/14fvom weekly
https://invst.ly/14fvq9 daily
rsi stregth index looking stronger break above 0.90 bring it out of o/s
How can we still be at this stage.
Every update we go backwards!
We’re much further ahead than that.
Look a teeny Aptamer Group RNS this morning partnering with Kairos Biotech, and the size of the market they are targeting.
Nuvec is proving itself, and the patents in all major Global territories make this very interesting indeed.